Come Join Me

I will be chairing a session at the Global Cardiovascular Clinical Trialists Forum on December 8 in Washington DC

Business builder and adviser

Nancy A. Dreyer, MPH, PhD, FISPE

Serial Entrepreneur
Demonstrated Business Success Clear Thinker and Strong Leader

Nancy Dreyer operates an independent consultancy after having retired as Chief Scientific Officer of IQVIA Real World Solutions. She also is Adjunct Professor of Epidemiology at the University of North Carolina at Chapel Hill and a Trustee of Brandeis University. Well-known for her thought leadership, she has helped advance the use of real-world evidence for clinical and regulatory decision support, influencing the content of guidelines by regulators in the US, Europe, and China, each of which cite her publications. Her experience includes biopharmaceutical, occupational and environmental research.

Her substantial executive and field experience have helped hone her pragmatic views.

Profile overview

Areas of expertise

Education & Honors

Recent External highlights

35+ years of experience in epidemiology and business including

IQVIA, SVP and Chief Scientific Officer
Quintiles/Outcome Sciences Inc, SVP, Chief of Scientific Affairs
i3 Research/Ingenix, UnitedHealth Group, SVP
Epidemiology Resources, Inc. and the New England Epidemiology Institute, CEO & Chair of the Board

Developing reliable real-world evidence (RWE) derived from person-generated health data, electronic medical records and/or pharmacy and medical claims
Regulatory use of RWE for market authorization, label expansion, and post-marketing safety commitments
Assessing the relevance and reliability of RWE for decision support
Real-world data linkage

BA, Brandeis University
Master of Public Health, Epidemiology, University of North Carolina
PhD, Epidemiology, University of North Carolina
Fellow, International Society of Pharmacoepidemiology
Fellow, Drug Information Association

Brandeis University, Trustee
Drug Information Association, Scientific & Policy Advisory Council and former Director
Duke-Margolis Center for Health Policy Research Planning Board
University of North Carolina Gillings School of Public Health, Adjunct Professor of Epidemiology

LEARN MORE

Selected Recent Publications

Su L, Chen L, Betigeria S, Dreyer N et al. Clinical trials with real-world pragmatic elements: A scoping review of use cases and real-world data utilization. Clinical Pharmacology & Therapeutics. August 19, 2025; https://doi.org/10.1002/cpt.70033.
Khozin S, Dreyer NA, Galante D et al. Real-world evidence acceptability and use in breast cancer treatment decision-making in the US: Call-to-action from a multidisciplinary think tank. Advances in Therapy 2025; May 12: https://doi.org/10.1007/s12325-025-03201-y
Riskin D, Monda KL, Gagne JJ, Reynolds R, Garan AR, Dreyer N, Muntner P, Bradbury B. Data Reliability: Implementation of accuracy, completeness, and traceability. JAMA Open 2025;8(3):e250128. doi:10.1001/jamanetworkopen.2025.0128
Hernandez RK, Critchlow CW, Dreyer N et al. Advancing Principled Pharmacoepidemiologic Research to Support Healthcare Decision-Making: The Era of Real-world Evidence. Clinical Pharmacology & Therapeutics 2025. https://doi.org/10.1002/cpt.3563
Dreyer NA and Blackburn SCF. Power to the people: Why person-generated health data is important for pharmacoepidemiology. American Journal of Epidemiology 2024: https://doi.org/10.1093/aje/kwae035
Dreyer NA et al. COVID-19 vaccination reactions and risk of breakthrough infections among people with diabetes: cohort study derived from community reporters. JMIR Diabetes 2024; e45536, https://diabetes.jmir.org/2024/1/e45536/ doi: 10.2196/45536

SEE ALL BOOKS, ARTICLES & PUBLICATIONS

Contact